Latest News about PRVB
Recent news which mentions PRVB
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
November 03, 2022
From Benzinga
Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results
November 03, 2022
From Benzinga
Crude Oil Down Over 1%; Lincoln National Shares Plunge
November 03, 2022
From Benzinga
US Stocks Open Lower; Nasdaq Drops 100 Points
November 03, 2022
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
From Motley Fool
From Benzinga
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
October 10, 2022
From Benzinga
From Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
October 07, 2022
From Benzinga
From Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
From Benzinga
From Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
October 06, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 06, 2022
From Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 06, 2022
From Benzinga
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
October 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
September 20, 2022
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2022
August 12, 2022
From Motley Fool
This Stock Could Soar by Nearly 300%, Says Wall Street
July 26, 2022
From Motley Fool
Get in front of these three stock market sectors before they blossom into mainstream darlings
July 22, 2022
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
U.S. FDA Extends Review By Three Months For Provention Bio's Type 1 Diabetes Candidate
June 30, 2022
Tickers
PRVB
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|